5-Hydroxy-6-methoxyindole glucuronide
|
Basic information |
| Metabolite name | 5-Hydroxy-6-methoxyindole glucuronide |
 | HMDB0010363 |
 |
C03033 |
 |
196512 |
| Synonyms | 5-Hydroxy-6-methoxyindole glucurnoide |
| No. of studies | 3 |
|
Basic information |
| Metabolite name | 5-Hydroxy-6-methoxyindole glucuronide |
| HMDB0010363 |
|
C03033 |
|
196512 |
| Synonyms | 5-Hydroxy-6-methoxyindole glucurnoide |
| No. of studies | 3 |
|
Relationship between 5-Hydroxy-6-methoxyindole glucuronide and depression (count: 3) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M012 | Type1 | CVS group vs. control group | Urine | Wistar rat | Up |
| Study M012 | Type2 | CVS + CSGS group vs. CVS group | Urine | Wistar rat | Down |
| Study M012 | Type2 | CVS + fluoxetine group vs. CVS group | Urine | Wistar rat | Down |
| Study M053 | Type1 | CUMS group vs. control group | Urine | Wistar rat | Up |
| Study M053 | Type2 | CUMS + CSGS group vs. CUMS group | Urine | Wistar rat | Down |
| Study M867 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |